Perrigo Company plc (NYSE:PRGO) Receives Consensus Recommendation of “Hold” from Analysts

Posted by on Aug 24th, 2026

Shares of Perrigo Company plc (NYSE:PRGO – Get Free Report) have earned a consensus rating of “Hold” from the six brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $19.3333.

Several equities analysts recently issued reports on the company. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised shares of Perrigo from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th.

View Our Latest Stock Report on Perrigo

Hedge Funds Weigh In On Perrigo

Several hedge funds and other institutional investors have recently modified their holdings of the company. Geneos Wealth Management Inc. grew its stake in shares of Perrigo by 439.1% in the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after purchasing an additional 786 shares during the last quarter. Kestra Investment Management LLC lifted its holdings in Perrigo by 57.1% in the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after buying an additional 642 shares during the period. EverSource Wealth Advisors LLC grew its position in shares of Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock worth $26,000 after buying an additional 1,014 shares during the last quarter. UMB Bank n.a. grew its position in shares of Perrigo by 161.5% in the 4th quarter. UMB Bank n.a. now owns 1,964 shares of the company’s stock worth $27,000 after buying an additional 1,213 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Perrigo during the fourth quarter valued at approximately $28,000. 95.91% of the stock is owned by institutional investors.

Perrigo Trading Down 0.4%

Perrigo stock traded down $0.06 during mid-day trading on Monday, hitting $14.19. The company’s stock had a trading volume of 119,048 shares, compared to its average volume of 3,141,171. The business has a 50 day moving average price of $11.07 and a 200-day moving average price of $11.42. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. Perrigo has a 12 month low of $9.23 and a 12 month high of $24.49. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of -1.13, a price-to-earnings-growth ratio of 1.62 and a beta of 0.51.

Perrigo (NYSE:PRGO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts forecast that Perrigo will post 2.2 EPS for the current year.

Perrigo Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 8.2%. The ex-dividend date of this dividend is Friday, August 28th. Perrigo’s dividend payout ratio (DPR) is -9.27%.

About Perrigo

(Get Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.

Featured Articles

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.